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Folic acid supplementation is important in the prevention of Neural 
Tube Defects (NTD). The study was conducted to assess the aware-
ness amongst physicians regarding the role of Folic Acid (FA) in 
the prevention of NTD. Physicians were interviewed regarding the 
awareness of FA dose, timing of supplementation and knowledge 
about its role in prevention of neural tube defects using a semi-
structured questionnaire. Among 202 physicians interviewed (48 
pediatricians, 54 obstetricians, 100 recently qualified medical 
graduates) overall awareness about FA was present in 92.07%, 
similar in three groups (P > 0.05). Only 47.52% were aware of pre-
conception administration, 61.38% about dose of supplementation 
and 11.88% about recurrence rate of NTD. Only 15 (7.4%) knew 
all these. Regarding the etiology of NTDs only 26.7% said both FA 
and genetic factors are involved. Though majority were aware that 
folic acid has a role in prevention of NTDs, their knowledge about 
timing and dose of supplementation was lacking. Hence attempts 
should be made to increase the awareness regarding prevention of 
NTD’s by FA supplementation at a proper time. 
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Summary
Introduction
Neural Tube Defects (NTD) are group of defects which 
result from failure of the closure of neural tube between 
3rd and 4th week of gestation. Its spectrum varies from 
conditions incompatible with life (anencephaly) to con-
ditions which might go unnoticed (spina bifida occulta). 
NTD has multi factorial etiology but supplementation of 
Folic Acid (FA) in maternal diet has been found to re-
duce its incidence. Today most of the developed nations 
recommend daily intake of 400 microgram FA pre-con-
ception, continued into first trimester. Many countries 
advocate flour fortification with folic acid [1]. Countries 
like USA and Canada have significantly brought down 
the incidence of NTD by universal supplementation of 
folic acid before and during pregnancy [2, 3].
The incidence of NTD in India varies from 0.5-11/1000 
live births [4]. Since health care providers are an im-
portant means of spreading awareness, we conducted a 
study to test the knowledge of physicians (pediatricians, 
obstetrician and recently qualified medical graduates) on 
role the of FA supplementation for prevention of NTD.
Methods
Research participants were 100 recently qualified medi-
cal graduates, 48 Pediatricians and 54 obstetricians. 
They were interviewed by using a semi structured ques-
tionnaire after an informed consent. A semi structured 
questionnaire consisted of questions regarding the dose, 
duration and timing of folic acid supplementation. Their 
knowledge regarding the etiology, screening and preven-
tion of NTD was also assessed. Open ended questions 
were asked regarding, dose, timing and etiology. Daily 
dose of 0.4 mg for primary prevention and 4 mg for sec-
ondary prevention was considered correct. A recurrence 
risk of 3-5% was taken as correct answer. Results were 
analyzed using EPI info and odds ratio was calculated 
for difference in knowledge among the three groups.
Results
Overall 92.1% were awareness about the role of FA: ob-
stetricians (98.14%), pediatrician (97.9%) and recently 
passed medical graduates (87%). Only 35.1% were aware 
about both correct dose and preconceptional administra-
tion of folic acid (47.52% knew about preconceptional 
administration and 61.38% knew about the dose of sup-
plementation). When asked about the etiology: 33.6% 
implicated genetic reasons, 27% implicated FA defi-
ciency, 26.7% said both and 12.3% were unaware of 
the etiology. Table 1. depicts the awareness about folic 
acid in various groups and their comparison. There was 
significant difference in the three groups (p < 0.05) re-
garding awareness of dose and preconception adminis-
tration of folic acid but no difference in awareness of 
recurrence rate which was uniformly low (11.88%). 
When pediatricians and obstetricians were compared to 
recently qualified medical graduates awareness about 
the dose was significantly more in obstetricians and 
pediatricians (P < 0.001, odds ratio 4.2, CI-2.19-8.10). 
Knowledge about preconceptional administration was 
more in obstetricians and gynecologists compared to re-
cently qualified medical graduates (P < 0.001, odds ratio 
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3.58, CI1.92-6.69). Only 15 (7.4%) had correct answers 
to all the four facts in table 1. Seventy one (35.1%) were 
aware of folic acid, its dose and preconception admin-
istration. Seventy one percent acquired this knowledge 
from books and 26.7% were aware that etiology is ge-
netic as well as environmental.
Discussion and conclusions
Our study showed that although most of the physicians 
knew about the role of FA in prevention of NTDs most 
of them did not know the correct dosage, timing and 
duration of administration of folic acid required. There 
was considerable lack of knowledge regarding role of 
FA supplementation in the prevention and recurrence of 
NTDs, especially about the dose and the fact that it has 
to be given before conception. Obstetricians had bet-
ter awareness about the various aspects studied. These 
findings are similar to the study by Huaser and Lilly 
(2004) where 89% of obstetricians as compared to 65% 
of the pediatrician knew about the recommended dose 
of FA [5].
We also found that awareness is less at the end of medi-
cal curriculum compared to doctors with some experi-
ence. Since the numbers were small we could not ran-
domize the subjects according to their maximum quali-
fication and the years of experience in the concerned 
specialty.
Among 48 pediatricians, 54 obstetricians, 100 recently 
qualified medical graduates overall awareness about FA 
was similar in the three groups. But only 15 (7.4%) were 
aware of preconception administration, supplementation 
and recurrence rate of NTD. Folic acid was implicated in 
etiology by 26.7%. Hence though majority were aware 
that folic acid has a role in prevention of NTDs, their 
knowledge about timing and dose of supplementation 
was lacking. Therefore we need to increase the aware-
ness among all health care professionals regarding pre-
vention of NTDs by FA supplementation before concep-
tion in adequate doses. This needs to be emphasized in 
medical curriculum as well.
Tab. I. awareness about folic acid in various groups.
Pediatricians
N = 48
No. (%)
Obstetricians
N = 54
No. (%)
Recent graduates
N = 100
No. (%)
Total
N = 202
(%)
folic acid
 -aware
 -unaware
47 (97.9)
1 (2.08)
53 (98.14)
1 (1.85)
86(86)
14(14)
92.08
7.92
dose*
 - aware
 - unaware
33(68.75)
15 (31.25)
46 (85.18)
81 (4.8)
45(45)
55(55)
61.38
38.61
preconception*
 -aware
 -unaware
24 (50)
24 (50)
40 (74.07)
14 (25.92)
32(32)
68(68)
47.52
52.47
recurrence
 -aware
 -unaware
3 (6.25)
45 (93.75)
9 (16.6)
45 (83.33)
12(12)
88(88)
11.88
88.11
* p < 0.05 (comparison of three groups).
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